Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis: A randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots

International Journal of Clinical Pharmacology and Therapeutics

Volumn 48, Issue 3, 2010, Pages 184-191

  Kamin, W ^a   Maydannik, V ^b   Malek, F A ^c   Kieser, M ^d  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute bronchitis; Bronchitis specific symptoms; Children and adolescents; EPs 7630; Herbal drug preparation

Indexed keywords

ANTIBIOTIC AGENT; PELARGONIUM SIDOIDES EXTRACT; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BED REST; BRONCHITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; TREATMENT RESPONSE;

EID: 77949454253     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP48184     Document Type: Article

References (25)

1. Agbabiaka TB, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: Asystematic review and meta-analysis. Phytomedicine. 2008; 15: 378-385.
2. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics. 1994; 50: 1029-1041.
3. Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs® 7630): a randomized, double-blind, placebo-controlled trial. Explore. 2005; 1: 437-445.
4. Conrad A, Hansmann C, Engels I et al. Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine. 2007; 14 (Suppl VI): 46-51.
5. Conrad A, Jung I, Tioua D et al. Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine. 2007; 14 (Suppl VI): 52-59.
6. Dome L, Schuster R. Umckaloabo - eine phytotherapeutische Alternative bei akuter Bronchitis im Kindesalter? Ärztezeitschr Naturheilverfahren. 1996; 37: 216-222.
7. Federal Statistical Office. Gesundheit - Krankheitskosten 2002 und 2004. Artikelnummer 523630104-9004. Wiesbaden: Statistisches Bundesamt. 2007; 39-40.
8. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003; 163: 487-494.
9. File TM, Hadley JA. Rational use of antibiotics to treat respiratory tract infections. Am J Manag Care. 2002; 8: 713-727.
10. Flaherty KR, Saint S, Fendrick AM, Martinez FJ. The spectrum of acute bronchitis. Using baseline factors to guide empirical therapy. Postgrad Med. 2001; 109: 39-47.
11. Haidvogl M, Heger M. Treatment effect and safety of EPs® 7630-solution in acute bronchitis in childhood: Report of a multicentre observational study. Phytomedicine. 2007; 14 (Suppl VI): 60-64.
12. Hueston WJ, Mainous AG 3rd. Acute bronchitis. Am Fam Physician. 1998; 57: 1270-1276.
13. Kayser O, Kolodziej H, Kiderlen AF. Immuno-modulatory principles of Pelargonium sidoides. Phytother Res. 2001; 15: 122-126.
14. Kolodziej H. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo® . Phytomedicine. 2007; 14 (Suppl VI): 9-17.
15. Kolodziej H, Kayser O, Radtke OA, Kiderlen AF. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine. 2003; 10 (Suppl VI): 18-24.
16. Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630. Phytomedicine. 2007; 14 (Suppl VI): 18-26.
17. Koren G, Prober CG, Gold R (eds). Antimicrobial therapy in infants and children. New York: Marcel Dekker; 1988. p. 1-805.
18. Little P, Rumsby K, Kelly J et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection. JAMA. 2005; 293: 3029-3035.
19. Lode H, Stahlmann R, Skopnik H. Rationaler Einsatz oraler Antibiotika bei Erwachsenen und Schulkindern (Lebensalter ab 6 Jahre). Chemother J. 2006; 15: 129-144.
20. Macfarlane J, Holmes W, Gard P et al. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomized controlled trial of patient information leaflet. BMJ. 2002; 324: 91-94.
21. Matthys H, Heger M. EPs® 7630-solution - an effective therapeutic option in acute and exacerbating bronchitis. Phytomedicine. 2007; 14 (Suppl VI): 65-68.
22. Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomized, doubleblind, placebo-controlled, multicentre study. Curr Med Res Opin. 2007; 23: 323-331.
23. Matthys H,KaminW,FunkP, HegerM.Pelargonium sidoides preparation (EPs® 7630) in the treatment of acute bronchitis in adults and children. Phytomedicine. 2007; 14 (Suppl VI): 69-73.
24. Neugebauer P, Mickenhagen A, Siefer O, Walger M. A new approach to pharmacological effects on ciliary beat frequency in cell cultures - exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine. 2005; 12: 46-51.
25. Williamson HA. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract. 1984; 19: 481-486.